ICarbonX
Provider of bioinformatic platforms for health management and drug development
About This Fund
ICarbonX is a corporate investor (Omics Analysis) founded in 2015 and headquartered in Shenzhen, Guangdong Province, china. iCarbonX provides a bioinformatics platform for health management and drug development. It plans to use big data and artificial intelligence to analyze omic data along with phenotypic, social, and environmental information. The analysis would be used by individuals for health management and by pharma companies for drug development. Solutions offered are Hey me, Healthtell immune response chip, and DigitalMe. Hey me is a digital health management platform that features genetic testing, sports data tracking, prediction, customized sports programs, personalized beauty products according to skin type, personalized dietary plans. DigitalMe is a health platform that tracks the health of patients suffering from chronic disease. Practice areas include Life Sciences and HealthTech. The firm operates as Life Sciences Tech. Key investment sectors include Artificial Intelligence, Healthcare / HealthTech, and Semiconductors.
Investment Focus
Preparing to pitch ICarbonX?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →